1

Orion Corporation

#2321

Rank

$6.63B

Marketcap

FI Finland

Country

Orion Corporation
Leadership team

Dr. Liisa Hurme (Pres, CEO & Chairman of Exec. Management Board)

Mr. Timo Lappalainen (Advisor)

Mr. Jari Karlson M.Sc., M.Sc. (Econ.) (CFO, Sr. VP of Animal Health & Member of the Exec. Management Board)

Products/ Services
Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Espoo, Southern Finland, Finland
Established
1970
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
ORNAV.HE
Social Media
Overview
Location
Summary
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories, as well as consumers with pets. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) product portfolio for the treatment of asthma and COPD; and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop new bispecific antibody cancer therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.
History

Orion was founded on September 21, 1917 by pharmacists Onni Turpeinen, Eemil Tuurala and Wikki Valkama. Before founding Orion, they worked in a pharmaceutical-chemical factory called Medica. The first premises of the new company were found in a courtyard building in Helsinki's Kruununhaa, Mariankatu 24, i.e. Asunto Oy Mars star. Among the first products of the apothecary were Bellistol gun oil and dulcine. Pediatrician Arvo Ylppö played a significant role starting in the 1920s.Orion's diagnostics business was previously concentrated in the Orion Diagnostica profit unit, which was sold to a private equity investor in April 2018. The diagnostics business included the development, manufacture and marketing of diagnostic tests and hygiene tests. Orion Diagnostica changed its name in November 2019 and is now Aidian.

Mission
Mission to build well-being
Vision
Our vision is to be the global leader in medical diagnostics, allowing clinicians to make more informed decisions and healthcare providers to deliver the most efficient care.
Key Team

Ms. Virve Laitinen M.Sc. (Tech.), MBA (Sr. VP of Specialty Products & Member of Exec. Management Board)

Mr. Olli Huotari Ll.M. (Sr. VP of Corp. Functions, Gen. Counsel, Sec. & Member of Exec. Management Board)

Prof. Outi Vaarala M.D., Ph.D. (Sr. VP for R&D and Member of Exec. Management Board)

Ms. Satu Ahomäki M.Sc., M.Sc. (Econ.) (Sr. VP of Commercial Operations & Member of the Exe. Mgmt. Board)

Ms. Terhi Ormio (VP of Communications)

Mr. Juhani Kankaanpaa (Sr. VP of Global Operations & Member of Exec. Management Board)

Mr. Tuukka Hirvonen M.Sc.(Soc.) (Investor Relations & Financial Communications Officer)

Recognition and Awards
Orion Corporation has been recognized with numerous awards for excellence in innovation, customer service and product development, from organizations such as the American Association for Clinical Chemistry , the International Society for Clinical Chemistry and Laboratory Medicine , and the European Diagnostic Manufacturers Association .
References
Orion Corporation
Leadership team

Dr. Liisa Hurme (Pres, CEO & Chairman of Exec. Management Board)

Mr. Timo Lappalainen (Advisor)

Mr. Jari Karlson M.Sc., M.Sc. (Econ.) (CFO, Sr. VP of Animal Health & Member of the Exec. Management Board)

Products/ Services
Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Espoo, Southern Finland, Finland
Established
1970
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
ORNAV.HE
Social Media